AlphaQuest’s Xeris Biopharma Holdings XERS Stock Holding History

AlphaQuest’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,204	Closed	-$9.45K	–	2126
2025 Q4	$9.45K	Sell	1,204 -3,096	-72%	-$24.4K	﹤0.01%	2158
2025 Q3	$35K	Buy	+4,300	New	+$28.6K	﹤0.01%	2012

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AlphaQuest's XERS Position: Q1 2026 in Review

AlphaQuest sold out of Xeris Biopharma Holdings (XERS) in Q1 2026, closing a stake of 1,204 shares — an estimated $9.45K sold.

AlphaQuest first reported a position in XERS in Q3 2025 and held it in 2 quarters. The position peaked at $35K in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

AlphaQuest reported no remaining Xeris Biopharma Holdings position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 1,204 Xeris Biopharma Holdings shares in Q1 2026, an estimated $9.45K.
AlphaQuest first reported a position in Xeris Biopharma Holdings in Q3 2025 and held it in 2 quarters.
AlphaQuest's Xeris Biopharma Holdings position peaked at $35K in Q3 2025.
237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.